Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T19873 |
Edoxaban M4
D21-2393,D21 2393,UNII-IV344R972X,Edoxaban 4-Carboxylic Acid |
Others | Others |
D21-2393 subjects received a single-oral-dose of edoxaban 30-90 mg in each study occasion under fasting condition. Serial blood samples were collected to measure the plasma concentrations of edoxaban and its major active metabolite D21-2393. Meanwhile, PT, INR, aPTT were measured pre- and post-dose. |